The Scientist

» biotechnology and developmental biology

Most Recent

image: Leaving an Imprint

Leaving an Imprint

By | August 1, 2015

Among the first to discover epigenetic reprogramming during mammalian development, Wolf Reik has been studying the dynamics of the epigenome for 30 years.

1 Comment

image: Mimicry Muses

Mimicry Muses

By | August 1, 2015

The animal world is full of clever solutions to bioengineering challenges.

0 Comments

image: Mr. Epigenetics

Mr. Epigenetics

By | August 1, 2015

Meet Wolf Reik, August Profilee and Babraham Institute director of research.

0 Comments

image: Rethinking Lymphatic Development

Rethinking Lymphatic Development

By | August 1, 2015

Four studies identify alternative origins for cells of the developing lymphatic system, challenging the long-standing view that they all come from veins.

1 Comment

image: RoboSpleen

RoboSpleen

By | August 1, 2015

Witness a bioinspired device developed by researchers at Harvard’s Wyss Institute to treat sepsis.

1 Comment

image: Inspired by Nature

Inspired by Nature

By | August 1, 2015

Researchers are borrowing designs from the natural world to advance biomedicine.

0 Comments

image: The Prescient Placenta

The Prescient Placenta

By | August 1, 2015

The maternal-fetal interface plays important roles in the health of both mother and baby, even after birth.

1 Comment

image: Biotech Buys Autoimmune Firm for $7B

Biotech Buys Autoimmune Firm for $7B

By | July 16, 2015

Celgene has purchased Receptos, developer of an experimental multiple sclerosis drug.

0 Comments

image: FDA OKs Herpes Blood Test

FDA OKs Herpes Blood Test

By | July 6, 2015

The US Food and Drug Administration approves Theranos’s fingerstick test for herpes.

0 Comments

image: CAR-T Therapies Get $1 Billion Boost

CAR-T Therapies Get $1 Billion Boost

By | July 1, 2015

The biotech firm Celgene inks a huge collaboration deal with Juno Therapeutics to develop and commercialize new cancer immunotherapies.

0 Comments

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. How Plants Evolved Different Ways to Make Caffeine
  3. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  4. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

RayBiotech